Wordt geladen...
RGD-FasL Induces Apoptosis in Hepatocellular Carcinoma
Despite impressive results obtained in animal models, the clinical use of Fas ligand (FasL) as an anticancer drug is limited by severe toxicity. Systemic toxicity of death ligands may be prevented by using genes encoding membrane-bound death ligands and by targeted transgene expression through eithe...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4002720/ https://ncbi.nlm.nih.gov/pubmed/19728930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cmi.2009.38 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|